" class="no-js "lang="en-US"> Companies Archive - Page 33 of 145 - Medtech Alert
Saturday, October 11, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
1448 Results.

View Company

 Alpenglow Biosciences | Pharmtech Focus

Alpenglow Biosciences

View Company

 Greater Good Health | Pharmtech Focus

Greater Good Health

View Company

 KromaTiD | Pharmtech Focus

KromaTiD

View Company

 Celularity | Pharmtech Focus

Celularity

View Company

 SK bioscience | Pharmtech Focus

SK bioscience

View Company

 Retia Medical | Pharmtech Focus

Retia Medical

View Company

 Jumpstart Nova | Pharmtech Focus

Jumpstart Nova

View Company

 Evergreen Nephrology | Pharmtech Focus

Evergreen Nephrology

View Company

 Humanity Health | Pharmtech Focus

Humanity Health

View Company

 New Jersey Innovation Institute (NJII) | Pharmtech Focus

New Jersey Innovation Institute (NJII)

Load More Results